Carl Maki to Triple Negative Breast Neoplasms
This is a "connection" page, showing publications Carl Maki has written about Triple Negative Breast Neoplasms.
Connection Strength
1.621
-
Novel markers of MCL1 inhibitor sensitivity in triple-negative breast cancer cells. J Biol Chem. 2024 Jun; 300(6):107375.
Score: 0.911
-
Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther. 2020 11 01; 21(11):1033-1040.
Score: 0.710